Compare Godaddy Inc (GDDY) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Godaddy Inc vs Immunovant Inc. Common Stock — how do they compare? Godaddy Inc trades at $101.56 (market cap $12.31B), while Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B). The key difference: Godaddy Inc is the larger of the two by market cap, and Godaddy Inc is more actively traded (1,477,265 versus 1,131,364). Which is the better fit depends on your goals — on Pluang, investors hold Godaddy Inc for 65 Days and Immunovant Inc. Common Stock for 0 Days on average.
| GDDY | IMVT | |
|---|---|---|
Market Cap | $12.31B | $6.62B |
Volume | 1,477,265 | 1,131,364 |
Sector | Technology | Health |
52-Week High | $135.18 | $44.96 |
52-Week Low | $75.07 | $17.03 |
Typical Hold Time | 65 Days | 0 Days |
Enterprise Value | $15.00B | $5.72B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GoDaddy (GDDY) trades at $103.19, up 5.1% on the day, with a bullish technical signal from moving averages and a neutral RSI. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue growth is steady, reaching $5.0B in 2025, and profitability metrics like a 17.83% net income margin and 14.44 P/E ratio indicate solid fundamentals. However, a class action lawsuit filed in late September 2026 over alleged securities fraud has heightened investor scrutiny.
The stock presents a mixed outlook: analyst consensus is bullish with a $96.20 price target, but legal risks and high debt levels pose concerns. Near-term performance hinges on Q3 earnings and lawsuit developments, with support at $96 and resistance at $100. Investors should weigh strong operational cash flow against elevated equity and litigation overhangs.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Godaddy Inc
GoDaddy is a provider of domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro- to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.
Read more on GDDY →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
